Treatment of Patients with Glaucoma in the Postoperative Period

The purpose of the study To study the effects of drugs affecting neurotransmitters - of neuromidin in patients undergoing antiglaucoma surgery. Material and methods 95 patients (190 eyes), operated on for uncompensated primary open angle glaucoma, divided into 2 groups. The first (main) group: 65 patients, which, together with the local hypotensive drugs and traditional therapy was received neiromidin 15 mg (1 ml) intramuscularly, and then in tablets of 20 mg x 2 times daily outpatient as monotherapy, 20 days. The second (control) group: 30 patients (60 eyes), who received similar treatment, but without the neuromidin. All of the patients were made classical surgery fistulizing with peripheral iridectomy modification S.N. Fedorov et al. The paper uses the standard ophthalmological research methods: visometry, tonometry, biomicroscopy, direct and inverse ophthalmoscopy, dynamic and static perimetry, gonioskopia and quantify disk on Heidelberg retina tomograph by laser scanning. The research was carried out before beginning treatment at hospital discharge and in process through 1, 3, 6, 9, 12 months. Results and their discussion Underwent surgical intervention resulted in lowering intraocular pressure in the main and control groups. In the group of patients treated with neuromidin, more marked significant improvement of visual functions, indicators HRT. Conclusion With the purpose of increase of efficiency of treatment of patients with primary glaucoma in the postoperative period it is recommended in complex treatment include neuromidin.The addition of neuromidin to traditional therapy improves visual acuity, the expansion of the field of view and increase the area of neironal rim, thickening peripapillary nerve fiber layer of the retina. Taking into account the decrease received positive effect six months after the operation, courses of drug therapy should be carried out 2 times in year.

glaucoma, postoperative period, neiromidin